Cipher Pharmaceuticals Inc
TSX:CPH
Cipher Pharmaceuticals Inc
TSX:CPH
Price:
14.98
CAD
0.6%
Market Closed
Market Cap:
CA$380m
Relative Value
The Relative Value of one
CPH
stock under the Base Case scenario is
hidden
CAD.
Compared to the current market price of 14.98 CAD,
Cipher Pharmaceuticals Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CPH Relative Value
HIDDEN
Multiples Across Competitors
CPH Competitors Multiples
Cipher Pharmaceuticals Inc Competitors
Cipher Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
380.8m CAD | 5.5 | 15.8 | 14.3 | 22.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
952.4B USD | 14.6 | 46.1 | 31.1 | 33.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
592.2B USD | 6.3 | 22.1 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282.2B CHF | 4.6 | 30.3 | 12.8 | 14.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
242.7B CHF | 5.6 | 22.5 | 13.9 | 17.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232.5B GBP | 5.4 | 30.9 | 17.1 | 24 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.8B USD | 4.6 | 16.4 | 10.1 | 12.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.8 | 8 | 9.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.6B USD | 2.4 | 19.5 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.8B USD | 2.6 | 17.8 | 7.4 | 9.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
